Kopalle Pharma Chemicals Profile
Key Indicators
- Authorised Capital ₹ 5.00 Cr
as on 17-12-2024
- Paid Up Capital ₹ 5.00 Cr
as on 17-12-2024
- Company Age 43 Year, 5 Months
- Last Filing with ROC 31 Mar 2022
- Satisfied Charges ₹ 43.74 Cr
as on 17-12-2024
- Revenue -60.11%
(FY 2022)
- Profit -11596.83%
(FY 2022)
- Ebitda 16.44%
(FY 2022)
- Net Worth -75.15%
(FY 2022)
- Total Assets -19.37%
(FY 2022)
About Kopalle Pharma Chemicals
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2022. It's a company limited by shares with an authorized capital of Rs 5.00 Cr and a paid-up capital of Rs 5.00 Cr.
The company has closed loans amounting to ₹43.74 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Bharat Gadiraju and Ramesh Gadiraju serve as directors at the Company.
- CIN/LLPIN
U24230TG1981PTC003101
- Company No.
003101
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
08 Jul 1981
- Date of AGM
30 Sep 2022
- Date of Balance Sheet
31 Mar 2022
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Kopalle Pharma Chemicals Pvt Ltd offer?
Kopalle Pharma Chemicals Pvt Ltd offers a wide range of products and services, including Organic and Inorganic Solvents, Alcohol Solvents.
Who are the key members and board of directors at Kopalle Pharma Chemicals?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ramesh Gadiraju  | Managing Director | 09-Dec-1989 | Current |
Board Members(1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Bharat Gadiraju | Director | 27-Jan-2012 | Current |
Financial Performance and Corporate Structure Insights of Kopalle Pharma Chemicals.
Kopalle Pharma Chemicals Pvt Ltd, for the financial year ended 2022, experienced significant reduction in revenue, with a 60.11% decrease. The company also saw a substantial fall in profitability, with a 11596.83% decrease in profit. The company's net worth observed a substantial decline by a decrease of 75.15%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Kopalle Pharma Chemicals?
In 2022, Kopalle Pharma Chemicals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 30 Mar 2016 | ₹23.15 Cr | Satisfied |
State Bank Of India Creation Date: 31 Mar 2000 | ₹20.59 Cr | Satisfied |
How Many Employees Work at Kopalle Pharma Chemicals?
Kopalle Pharma Chemicals has a workforce of 23 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Kopalle Pharma Chemicals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Kopalle Pharma Chemicals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
